Key result
Delaying anticoagulation therapy due to haemorrhagic transformation of an initial ischaemic stroke preceded an early, fatal recurrent stroke in a 72-year-old man with atrial fibrillation.
Why the study?
Determining when to initiate or reintroduce anticoagulation therapy after a recent stroke without increasing haemorrhagic risk remains a clinical challenge.
Case Report (n=1)
No
This case highlights the clinical dilemma and severe consequences of delaying anticoagulation in a patient with atrial fibrillation and an initial ischemic stroke complicated by hemorrhagic transformation.
Answers are grounded in this paper and cite their sources.
Underscores anticoagulation timing dilemma after AF stroke with haemorrhagic transformation; single case leaves optimal strategy open for prospective study.
Introduction: Anticoagulation therapy is used for the management of atrial fibrillation to prevent new clots from developing. However, neurologists face the challenge of when to initiate/reintroduce treatment after a recent episode of stroke without increasing haemorrhagic risk, especially if the stroke is large and/or complicated with haemorrhagic transformation. Case presentation: This report describes the case of a 72-year-old man who had an ischaemic stroke of the right posterior cerebral artery. The patient had permanent atrial fibrillation, discovered in hospital. He was not on chronic anticoagulation therapy before stroke. His anticoagulation therapy was postponed due to a haemorrhagic lesion, leading to new ischaemic stroke. The patient suddenly had right hemiplegia with aphasia for which a mechanical thrombectomy was performed but complicated by embolization into the left posterior cerebral artery with failure of thromboaspiration of this clot. Finally, the patient presented with intracranial hypertension due to ischaemic lesions and died 3 days after his readmission. Conclusion: When to start anticoagulation therapy after ischaemic stroke is an unresolved question but should be discussed at least twice weekly in a stroke unit based on the clinical evolution of the patient.
No takes yet. Share an insight, caveat, or question.
Aghetti et al. (2022) conducted a case report in Ischaemic stroke of cardioembolic cause (n=1). Delayed anticoagulation therapy was evaluated on Recurrent ischaemic stroke. Delaying anticoagulation therapy due to haemorrhagic transformation of an initial ischaemic stroke preceded an early, fatal recurrent stroke in a 72-year-old man with atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: